AXSOME THERAPEUTICS INC (AXSM) Stock Analyst Earnings Estimates
NASDAQ:AXSM - Nasdaq - US05464T1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.04M | 270.6M 440.77% | 385.693M 42.53% | 646.38M 67.59% | 1.06B 63.99% | 1.535B 44.81% | 2.043B 33.09% | 2.477B 21.24% | 2.753B 11.14% | 3.062B 11.22% | 3.315B 8.26% | |
| EBITDA YoY % growth | -174.9M -40.34% | -224.991M -28.64% | -272.604M -21.16% | 15.518M 105.69% | 296.87M 1,813.07% | 496.84M 67.36% | 739.81M 48.90% | 1.031B 39.36% | 1.255B 21.73% | 1.479B 17.85% | N/A | |
| EBIT YoY % growth | -179.3M -43.77% | -231.825M -29.29% | -280.562M -21.02% | -83.503M 70.24% | 187.66M 324.73% | 599.7M 219.57% | 999.43M 66.65% | 1.259B 25.97% | 1.514B 20.25% | 1.782B 17.70% | 1.882B 5.61% | |
| Operating Margin | -358.31% | -85.67% | -72.74% | -12.92% | 17.70% | 39.07% | 48.92% | 50.83% | 54.99% | 58.20% | 56.77% | |
| EPS YoY % growth | -4.57 -31.70% | -5.20 -13.79% | -5.41 -4.04% | -2.41 55.50% | 2.75 214.42% | 9.68 251.31% | 13.03 34.64% | 18.41 41.30% | 21.34 15.87% | 24.78 16.14% | 27.14 9.52% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.07 25.54% | -0.81 51.20% | -0.45 66.42% | -0.02 97.77% | 0.05 104.76% | 0.88 207.64% | 1.58 451.37% | 2.32 10,909.52% |
| Revenue Q2Q % growth | 124.78M 66.38% | 144.53M 65.81% | 170.18M 62.44% | 207.6M 74.79% | 204.41M 63.82% | 267.92M 85.37% | 319.58M 87.79% | 373.3M 79.82% |
| EBITDA Q2Q % growth | -36.757M 43.83% | -25.337M 65.86% | -1.469M 97.41% | 88.373M 236.68% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -48.447M 27.99% | -35.851M 54.06% | -17.397M 72.22% | 10.041M 113.83% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.96 53.85% | -1.04 | 0.08 | 7.32% |
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 -9.86% | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 -3.57% | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 -19.51% | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 -175.00% | -0.64 | -0.24 | -38.16% |
| Q4 2019 Q2Q % growth | -0.71 | -0.49 | -0.22 | -45.02% |
| Q3 2019 Q2Q % growth | -0.56 | -0.41 | -0.15 | -36.83% |
| Q2 2019 Q2Q % growth | -0.41 | -0.33 | -0.08 | -23.05% |
| Q1 2019 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 118.77M 66.04% | 120M | -1.23M | -1.03% |
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.07% | -23.43% | -13.22% | -9.1% |
| Revenue | 0.71% | 3.88% | -1.82% | 0.32% |